Tag Archives: Patent

March 1, 2018

Curasight have received US patent notification with issue date 6 February 2018 and patent number 9884131, please see attached. Curasight have provided a positron-emitting radionuclide labelled peptide for non-invasive PET imaging of the Urokinase-type Plasminogen Activator Receptor (uPAR) in humans. More specifically the invention relates to human uPAR PET imaging of any solid cancer disease […]